Zenicor Medical Systems AB (XSAT:ZENI) Cyclically Adjusted FCF per Share: kr-1.11 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSAT:ZENI Zenicor Medical Systems AB XSAT:ZENI
45 GF Score
Price kr0.95
GF Value kr1.03
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Zenicor Medical Systems AB Cyclically Adjusted FCF per Share?

Zenicor Medical Systems AB XSAT:ZENI -1.56% 45 Cyclically Adjusted FCF per Share is kr-1.11 as of Jun. 2026. GuruFocus rates XSAT:ZENI with a GF Score™ of 45/100 and a GF Value™ of kr1.03 (Fairly Valued). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Zenicor Medical Systems AB's adjusted free cash flow per share for the three months ended in Jun. 2026 was kr-0.066. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is kr-1.11 for the trailing ten years ended in Jun. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-09-10), Zenicor Medical Systems AB's current stock price is kr0.945. Zenicor Medical Systems AB's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was kr-1.11. Zenicor Medical Systems AB's Cyclically Adjusted Price-to-FCF of today is .


Zenicor Medical Systems AB  (XSAT:ZENI) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Zenicor Medical Systems AB Cyclically Adjusted FCF per Share Related Terms


Zenicor Medical Systems AB Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Zenicor Medical Systems AB's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zenicor Medical Systems AB Cyclically Adjusted FCF per Share Chart

Zenicor Medical Systems AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -1.14 -1.21 -1.16

Zenicor Medical Systems AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.20 -1.18 -1.16 -1.15 -1.11

XSAT:ZENI vs ABT, SYK, MDT: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, Zenicor Medical Systems AB's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zenicor Medical Systems AB Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Zenicor Medical Systems AB's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Zenicor Medical Systems AB's Cyclically Adjusted Price-to-FCF falls into.


XSAT:ZENI
45GF Score
Zenicor Medical Systems AB XSAT:ZENI
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zenicor Medical Systems AB Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Zenicor Medical Systems AB's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.066/134.6100*134.6100
=-0.066

Current CPI (Jun. 2026) = 134.6100.

Zenicor Medical Systems AB Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 -0.167 101.138 -0.222
201612 -0.616 102.022 -0.813
201703 0.059 102.022 0.078
201706 -0.113 102.752 -0.148
201709 0.404 103.279 0.527
201712 -0.465 103.793 -0.603
201803 -0.512 103.962 -0.663
201806 -0.434 104.875 -0.557
201809 -0.093 105.679 -0.118
201812 -0.780 105.912 -0.991
201903 -0.536 105.886 -0.681
201906 -0.263 106.742 -0.332
201909 -0.123 107.214 -0.154
201912 -0.081 107.766 -0.101
202003 -0.601 106.563 -0.759
202006 0.013 107.498 0.016
202009 0.110 107.635 0.138
202012 0.098 108.296 0.122
202103 0.039 108.360 0.048
202106 -0.283 108.928 -0.350
202109 -0.031 110.338 -0.038
202112 -0.325 112.486 -0.389
202203 -0.074 114.825 -0.087
202206 -0.630 118.384 -0.716
202209 -0.308 122.296 -0.339
202212 -0.015 126.365 -0.016
202303 -0.491 127.042 -0.520
202306 -0.592 129.407 -0.616
202309 -0.412 130.224 -0.426
202312 -0.338 131.912 -0.345
202403 -0.525 132.205 -0.535
202406 -0.363 132.716 -0.368
202409 -0.064 132.304 -0.065
202412 0.115 132.987 0.116
202503 -0.193 132.825 -0.196
202506 -0.319 133.699 -0.321
202509 -0.284 133.480 -0.286
202512 -0.202 133.390 -0.204
202603 -0.120 133.560 -0.121
202606 -0.066 134.610 -0.066

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of kr-1.11 mean?
Zenicor Medical Systems AB (XSAT:ZENI) has a Cyclically Adjusted FCF per Share of kr-1.11 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Zenicor Medical Systems AB and its competitors.
Is Zenicor Medical Systems AB's Cyclically Adjusted FCF per Share too high?
Zenicor Medical Systems AB's current Cyclically Adjusted FCF per Share is kr-1.11. Overall, Zenicor Medical Systems AB has a GF Score™ of 45/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Zenicor Medical Systems AB's Cyclically Adjusted FCF per Share compare to ABT and SYK?
Zenicor Medical Systems AB's Cyclically Adjusted FCF per Share of kr-1.11 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Zenicor Medical Systems AB and its competitors. Zenicor Medical Systems AB's current Cyclically Adjusted FCF per Share is kr-1.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zenicor Medical Systems AB stock overvalued right now?
Based on GuruFocus' analysis, Zenicor Medical Systems AB (XSAT:ZENI) is currently considered Fairly Valued. The stock's GF Value™ is kr1.03, compared to a current price of kr0.95 — trading 8.3% below its estimated fair value. The current Cyclically Adjusted FCF per Share is kr-1.11. Zenicor Medical Systems AB's overall GF Score™ is 45/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Zenicor Medical Systems AB (XSAT:ZENI), the current Cyclically Adjusted FCF per Share is kr-1.11 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zenicor Medical Systems AB (XSAT:ZENI) Overvalued in 2026?

Based on GuruFocus' analysis, Zenicor Medical Systems AB stock appears to be undervalued. The current stock price of kr0.95 is trading 8.3% below its estimated GF Value™ of kr1.03. GuruFocus considers Zenicor Medical Systems AB to be Fairly Valued.

Key valuation signals for XSAT:ZENI:

  • Cyclically Adjusted FCF per Share: kr-1.11
  • GF Value™: kr1.03 vs. price of kr0.95 (8.3% below fair value)
  • GF Score™: 45/100 with 7 warning signs

No single metric tells the full story. See the XSAT:ZENI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Zenicor Medical Systems AB Business Description

Address Saltmatargatan 8, Stockholm, SWE, 113 59
Zenicor Medical Systems AB is a medical technology company. It is engaged in remote diagnosis of cardiac care and stroke prevention.
45GF Score

Get the complete analysis for XSAT:ZENI

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.95
Price
kr1.03
GF Value